Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2022 3,500 · FY2023 2,748 · FY2024 5,770 — 3-yr total 12,018
Pharmaceutical manufacturer and part of the Aversi pharma group, one of Georgia's largest pharmacy chains.
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 31,294 | 22,626 | 33,693 | 39,215 | 51,337 | 58,499 | 59,765 | 63,771 | +10.7% |
| Total COGS | 17,423 | 14,004 | 21,026 | 25,038 | 33,746 | 38,392 | 35,022 | 36,548 | +11.2% |
| Gross Profit | 13,871 | 8,623 | 12,666 | 14,177 | 17,591 | 20,108 | 24,744 | 27,223 | +10.1% |
| Gross Margin | 44.3% | 38.1% | 37.6% | 36.2% | 34.3% | 34.4% | 41.4% | 42.7% | |
| 11,360 | 12,140 | 10,490 | 10,362 | 13,286 | 14,052 | 15,731 | 15,856 | +4.9% | |
| EBITDA | 2,511 | 3,518 | 2,177 | 3,815 | 4,305 | 6,055 | 9,013 | 11,367 | +24.1% |
| EBITDA Margin | 8.0% | 15.5% | 6.5% | 9.7% | 8.4% | 10.4% | 15.1% | 17.8% | |
| Total D&A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| EBIT / Operating Income | 2,511 | 3,518 | 2,177 | 3,815 | 4,305 | 6,055 | 9,013 | 11,367 | +24.1% |
| Total Interest Income | 237 | 98 | 169 | 199 | 185 | 172 | 118 | 82 | -14.0% |
| Total Interest Expense | 0 | 0 | 210 | 191 | 184 | 177 | 168 | 159 | -5.4% |
| Total Other Income | 0 | 219 | 285 | 461 | 244 | 375 | 247 | 193 | -2.1% |
| Profit Before Tax | 2,748 | 3,201 | 2,419 | 4,284 | 4,062 | 5,676 | 8,715 | 11,483 | +22.7% |
| Total Income Tax | 0 | 19 | 222 | 53 | 0 | 44 | 34 | 1,018 | +94.2% |
| Net Profit / (Loss) | 2,231 | 3,903 | 2,441 | 4,231 | 4,062 | 5,632 | 8,680 | 10,465 | +24.7% |
| Net Margin | 7.1% | 17.2% | 7.2% | 10.8% | 7.9% | 9.6% | 14.5% | 16.4% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set.